Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
83.62
+0.57 (+0.69%)
Streaming Delayed Price
Updated: 11:34 AM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
28
29
30
31
32
33
34
35
Next >
7 Members Of Congress Failed To Disclose Stock Transactions: Who Was Named, And What's Next?
September 24, 2021
The call for members of Congress to be banned from buying and selling stocks continues to heat up with a new report that seven members of the House of Representatives failed to...
Via
Benzinga
3 Relatively Safe Pharma Stocks You Can Buy Right Now
September 23, 2021
These stocks should be less volatile than many of the alternatives.
Via
The Motley Fool
EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile
September 21, 2021
NanoViricides Inc (NYSE: NNVC) has reported significant advantages gained by remdesivir encapsulation within its lead COVID-19 candidate, thus showing a potential pan-...
Via
Benzinga
Exposures
COVID-19
Barron's Latest Picks And Pans: Apple, Bitcoin, a Goldman Sachs ETF, Nike And More
September 18, 2021
This weekend's Barron's cover story examines the t...
Via
Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Analyzing Gilead Sciences's Unusual Options Activity
August 11, 2021
On Wednesday, shares of Gilead Sciences (NASDAQ:GILD) saw...
Via
Benzinga
Baidu, Gilead Sciences And Nvidia Stocks Provide Plays For Both Bulls And Bears: Here's How
September 17, 2021
Baidu. Inc (NASDAQ:BIDU), Gilead Sciences, Inc
Via
Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...
Via
Benzinga
Look For The Q4 Biotech Bounce In Mid-Small Caps
September 17, 2021
Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best...
Via
Talk Markets
Gilead Churns Out Additional Trodelvy Data
September 16, 2021
Gilead Sciences Inc (NASDAQ: GILD) announced new data from the Phase 3 ASCENT study of Trodelvy (sacituzumab govitecan-hziy) in relapsed or refractory metastatic...
Via
Benzinga
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
September 06, 2021
Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves for share prices. A company focused...
Via
Benzinga
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
August 31, 2021
Which subset of the COVID-19 healthcare market will outperform over the next year?
Via
The Motley Fool
Exposures
COVID-19
A Look Into Gilead Sciences Debt
August 31, 2021
Shares of Gilead Sciences (NASDAQ:GILD) rose by 7.09% in the past three months. Before we understand the importance of debt, let us look at how much debt Gilead Sciences...
Via
Benzinga
Galapagos' Long-Serving CEO Onno Van De Stolpe To Exit After R&D Setbacks
August 31, 2021
After 22 years at the helm of Galapagos NV (NASDAQ: GLPG), chief executive Onno van de Stolpe has decided it is time to retire and hand the reins to new...
Via
Benzinga
Could Moderna Take Down Gilead Sciences?
August 30, 2021
It's too early for a "yes" answer. But it's too premature for a "no" response as well.
Via
The Motley Fool
Gilead Wins Reversal of $1.2B Patent Loss to Bristol-Myers: Bloomberg
August 26, 2021
Gilead Sciences Inc (NASDAQ: GILD) persuaded a U.S. appeals court to reverse a $1.2 billion judgment Bristol-Myers Squibb & Co (NYSE: BMY) had won over immuno-...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Siemens' Fatty Liver Disease Blood Test Wins FDA De Novo Clearance
August 24, 2021
The FDA has granted clearance to a blood test from Siemens Healthineers (OTC: SMMNY) to provide an easier and potentially more accurate diagnostic alternative than an invasive...
Via
Benzinga
Exposures
Product Safety
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
August 23, 2021
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the...
Via
Talk Markets
Exposures
Product Safety
Why Fate Therapeutics Stock Is Sliding Today
August 20, 2021
The positive results the company announced after the bell yesterday didn't meet some lofty expectations.
Via
The Motley Fool
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Why NRx Pharmaceuticals Stock Jumped 11.8% Today
August 18, 2021
The company provided a positive update from a clinical study evaluating its COVID-19 therapy Zyesami.
Via
The Motley Fool
Exposures
COVID-19
China's Red Ribbon School Provides a Refuge for Children Living With HIV
August 18, 2021
China's Red Ribbon School Provides a Refuge for Children Living With HIV
Via
News Direct
Topics
Bonds
Product Recall
Exposures
Debt Markets
Legal
Product Safety
Wall Street Journal Creates A Pitch In Favor Of Royalty Pharma
August 17, 2021
Drug development, both a lucrative and a risky segment. Royalty Pharma plc (NASDAQ: RPRX) offers a middle ground for its investors. The Company was founded in 1996 and...
Via
Benzinga
Large Cap Biopharma Stocks provide Growth and Value
August 16, 2021
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
What To Know About Rand Paul Failing To Disclose Gilead Stock Purchase For 16 Months
August 12, 2021
Stock transactions by members of the U.S. Congress and their spouses have been a hot topic over the last several years. A transaction disclosed late Wednesday is drawing heavy...
Via
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week...
Via
Benzinga
Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program
August 11, 2021
Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program
Via
News Direct
Exposures
COVID-19
Stocks That Hit 52-Week Highs On Monday
August 16, 2021
Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs. Highlights: Apple (NASDAQ:AAPL) was the largest firm on a market cap basis to set a new 52-week...
Via
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
28
29
30
31
32
33
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.